1446712-19-1 Usage
General Description
3,5,7-Trihydroxy-8-(3-methyl-but-2-enyl)-2-(4-trifluoromethyl-phenyl)-chromen-4-one is a complex chemical compound with several functional groups. It contains three hydroxyl groups, a methylbutenyl group, and a trifluoromethylphenyl group attached to a chromen-4-one backbone. The compound has potential biological activity due to its multiple functional groups and the presence of a chromen-4-one moiety, which is known for its antioxidant and anti-inflammatory properties. However, further studies are needed to determine its specific pharmacological and toxicological effects. Additionally, the chemical's complex structure may make it challenging to synthesize and study in more detail.
Check Digit Verification of cas no
The CAS Registry Mumber 1446712-19-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,6,7,1 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1446712-19:
(9*1)+(8*4)+(7*4)+(6*6)+(5*7)+(4*1)+(3*2)+(2*1)+(1*9)=161
161 % 10 = 1
So 1446712-19-1 is a valid CAS Registry Number.
1446712-19-1Relevant articles and documents
Synthesis method of Fukelading
-
, (2017/10/13)
The invention provides a synthesis method of Fukelading. The method comprises the following step of using 3,5,7-trihydroxy-2-(4-trifluoromethyl phenyl)-4H-chromene-4-ketone as raw materials for preparing and obtaining icariine. The method has the advantages that in the re-arrangement reaction process, low-price easy-to-obtain silicon is used as a catalyst; by using the existing chemical synthesis method, the obtained Fukelading has few impurities; the purity can reach 98 percent; the yield can reach 50 percent.
SYNTHESIS OF POLYHYDROXY BENZOPYRAN KETONE COMPOUND AND ANTI-TUMOR EFFECT THEREOF
-
Paragraph 0059, (2014/12/09)
The present invention is directed to chromenone compounds of formula (I), pharmaceutically acceptable salts, prodrugs thereof, and the composition comprising the compounds or the like. They can be used to modulating the function of estrogen receptor ER-α36 preventing and/or treating the estrogen related diseases, such as breast cancer, leukemia, liver cancer and etc.
